- Home
- BDX vs EW Comparison
BDX vs EW Comparison
Compare BDX & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDX | EW |
|---|---|---|
| Founded | 1897 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.0B | 48.9B |
| IPO Year | 1998 | 1999 |
Fundamental Metrics
Financial Performance| Metric | BDX | EW |
|---|---|---|
| Price | $189.93 | $90.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 21 |
| Target Price | ★ $186.00 | $96.37 |
| AVG Volume (30 Days) | 1.8M | ★ 3.2M |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | ★ 2.89% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.59 | 1.07 |
| Revenue | ★ $21,840,000,000.00 | $6,067,600,000.00 |
| Revenue This Year | N/A | $13.39 |
| Revenue Next Year | $3.02 | $9.81 |
| P/E Ratio | $119.63 | ★ $84.84 |
| Revenue Growth | 8.24 | ★ 11.55 |
| 52 Week Low | $140.11 | $72.30 |
| 52 Week High | $213.08 | $96.29 |
Technical Indicators
Market Signals| Indicator | BDX | EW |
|---|---|---|
| Relative Strength Index (RSI) | 69.72 | 52.84 |
| Support Level | $188.28 | $81.19 |
| Resistance Level | $196.36 | $93.91 |
| Average True Range (ATR) | 3.91 | 1.77 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 75.86 | 35.34 |
Price Performance
Historical ComparisonAbout BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.